Registration Options

Register for the meeting and/or this session. (Additional registration required)
Pharmacogenomics Workshop RegistrationMembersNon-members
Pharmacogenomics Workshop Registration$95$115
Pharmacogenomics Workshop Fellow/Resident Registration$85$115
Pharmacogenomics Workshop Student Registration$75$115
Pharmacogenomics Workshop Bundle
(Save on Workshop + CPNP 2021 Registration)
MembersNon-members
Pharmacogenomics Bundle Registration$425$525
Pharmacogenomics Bundle Fellow/Resident Registration$275$360
Pharmacogenomics Bundle Student Registration$160$215

Session Time and Location

Date: Wednesday, 02/24/2021

Time: 1:00 PM (view in the schedule)

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Agenda

  • 1:00-1:10 Welcome and Introductions
  • 1:10-1:30 Clinical Relevance of PGx for Mental Health Medications
  • 1:30-1:45 PGx Report Data
  • 1:45-2:00 Why Pharmacists Need to Understand What is Being Tested
  • 2:10-2:30 Report Limitations and Caveats
  • 2:30-2:50 Guidelines and Regulations
  • 3:00-4:00 PGx Case Interpretation and Practice 
  • 4:10-4:30 PGx Patient Education
  • 4:30-4:45 Q&A

Summary

There has been significant growth in the use of pharmacogenomics (PGx) testing applied to the prescribing of psychiatric medications. Patients and providers may be unfamiliar with PGx tests, including resources available to aid in interpretation, as well as how to effectively communicate with patients and other providers about the reasons to (or not to test) and interpretation of the results. With the event of direct to consumer testing options, providers may also be uncertain of what to do when presented with a testing result, including understanding the evidence behind the results included. Furthermore, providers may not be comfortable counseling patients on PGx results due to their lack of direct experience with the tests. Therefore, this program will be geared toward the novice learner with intent to build and enhance pharmacists’ understanding of the current state of evidence for incorporating pharmacogenomics into patient care plans.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Attend and participate in the entire session and reflect upon its teachings.
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Jeff Bishop, PharmD, MS, BCPP
Vicki L. Ellingrod, PharmD, FCCP

View biographical information and disclosures

Learning Objectives

  1. Review current evidence behind the use of pharmacogenomics (PGx) testing for patients prescribed psychiatric and neurologic medications
  2. Discuss the literature regarding the genes/drug pairs commonly included on PGx tests, as well as the guidelines from Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and the Dutch Pharmacogenetics Working Group (DPWG) for testing result interpretation.
  3. Interpret PGx testing results and use results to inform therapeutic recommendations.
  4. Demonstrate patient counseling skills regarding communication involving PGx testing.

Continuing Education Credit and Disclosures

Activity Date: 02/24/2021
ACPE Contact Hours: 3.25
ACPE Number: 0284-0000-21-001-L01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.